NM_032776.3:c.1703A>T

Variant summary

Our verdict is Benign. The variant received -16 ACMG points: 0P and 16B. BP4_StrongBP6_Very_StrongBS2

The NM_032776.3(JMJD1C):​c.1703A>T​(p.Asp568Val) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.00153 in 1,614,010 control chromosomes in the GnomAD database, including 3 homozygotes. In-silico tool predicts a benign outcome for this variant. 16/22 in silico tools predict a benign outcome for this variant. Variant has been reported in ClinVar as Likely benign (★★). Another variant affecting the same amino acid position, but resulting in a different missense (i.e. D568G) has been classified as Uncertain significance.

Frequency

Genomes: 𝑓 0.00087 ( 0 hom., cov: 32)
Exomes 𝑓: 0.0016 ( 3 hom. )

Consequence

JMJD1C
NM_032776.3 missense

Scores

2
17

Clinical Significance

Likely benign criteria provided, multiple submitters, no conflicts B:3

Conservation

PhyloP100: 0.542

Publications

9 publications found
Variant links:
Genes affected
JMJD1C (HGNC:12313): (jumonji domain containing 1C) The protein encoded by this gene interacts with thyroid hormone receptors and contains a jumonji domain. It is a candidate histone demethylase and is thought to be a coactivator for key transcription factors. It plays a role in the DNA-damage response pathway by demethylating the mediator of DNA damage checkpoint 1 (MDC1) protein, and is required for the survival of acute myeloid leukemia. Mutations in this gene are associated with Rett syndrome and intellectual disability. Alternative splicing results in multiple transcript variants. [provided by RefSeq, Dec 2015]
JMJD1C Gene-Disease associations (from GenCC):
  • 22q11.2 deletion syndrome
    Inheritance: AD Classification: SUPPORTIVE Submitted by: Orphanet
  • complex neurodevelopmental disorder
    Inheritance: AD Classification: LIMITED Submitted by: Illumina
  • neurodevelopmental disorder
    Inheritance: AD Classification: LIMITED Submitted by: G2P

Genome browser will be placed here

ACMG classification

Classification was made for transcript

Our verdict: Benign. The variant received -16 ACMG points.

BP4
Computational evidence support a benign effect (MetaRNN=0.010563701).
BP6
Variant 10-63214464-T-A is Benign according to our data. Variant chr10-63214464-T-A is described in ClinVar as Likely_benign. ClinVar VariationId is 460224.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars.
BS2
High AC in GnomAd4 at 133 AD gene.

Transcripts

RefSeq

Gene Transcript HGVSc HGVSp Effect Exon rank MANE Protein UniProt
JMJD1CNM_032776.3 linkc.1703A>T p.Asp568Val missense_variant Exon 8 of 26 ENST00000399262.7 NP_116165.1 Q15652-1

Ensembl

Gene Transcript HGVSc HGVSp Effect Exon rank TSL MANE Protein Appris UniProt
JMJD1CENST00000399262.7 linkc.1703A>T p.Asp568Val missense_variant Exon 8 of 26 5 NM_032776.3 ENSP00000382204.2 Q15652-1
JMJD1CENST00000542921.5 linkc.1157A>T p.Asp386Val missense_variant Exon 7 of 25 1 ENSP00000444682.1 Q15652-3
JMJD1CENST00000402544.5 linkn.1675A>T non_coding_transcript_exon_variant Exon 5 of 22 1

Frequencies

GnomAD3 genomes
AF:
0.000874
AC:
133
AN:
152234
Hom.:
0
Cov.:
32
show subpopulations
Gnomad AFR
AF:
0.000362
Gnomad AMI
AF:
0.00
Gnomad AMR
AF:
0.000523
Gnomad ASJ
AF:
0.00
Gnomad EAS
AF:
0.00
Gnomad SAS
AF:
0.00
Gnomad FIN
AF:
0.0000941
Gnomad MID
AF:
0.00
Gnomad NFE
AF:
0.00159
Gnomad OTH
AF:
0.000478
GnomAD2 exomes
AF:
0.000944
AC:
235
AN:
248850
AF XY:
0.000933
show subpopulations
Gnomad AFR exome
AF:
0.000517
Gnomad AMR exome
AF:
0.00104
Gnomad ASJ exome
AF:
0.00
Gnomad EAS exome
AF:
0.0000557
Gnomad FIN exome
AF:
0.0000466
Gnomad NFE exome
AF:
0.00159
Gnomad OTH exome
AF:
0.00132
GnomAD4 exome
AF:
0.00159
AC:
2330
AN:
1461658
Hom.:
3
Cov.:
33
AF XY:
0.00152
AC XY:
1103
AN XY:
727136
show subpopulations
African (AFR)
AF:
0.000179
AC:
6
AN:
33480
American (AMR)
AF:
0.00103
AC:
46
AN:
44724
Ashkenazi Jewish (ASJ)
AF:
0.0000383
AC:
1
AN:
26132
East Asian (EAS)
AF:
0.00
AC:
0
AN:
39684
South Asian (SAS)
AF:
0.0000580
AC:
5
AN:
86256
European-Finnish (FIN)
AF:
0.000263
AC:
14
AN:
53282
Middle Eastern (MID)
AF:
0.000693
AC:
4
AN:
5768
European-Non Finnish (NFE)
AF:
0.00195
AC:
2163
AN:
1111942
Other (OTH)
AF:
0.00151
AC:
91
AN:
60390
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.483
Heterozygous variant carriers
0
125
249
374
498
623
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Exome Het
Exome Hom
Variant carriers
0
84
168
252
336
420
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
GnomAD4 genome
AF:
0.000873
AC:
133
AN:
152352
Hom.:
0
Cov.:
32
AF XY:
0.000631
AC XY:
47
AN XY:
74512
show subpopulations
African (AFR)
AF:
0.000361
AC:
15
AN:
41586
American (AMR)
AF:
0.000523
AC:
8
AN:
15302
Ashkenazi Jewish (ASJ)
AF:
0.00
AC:
0
AN:
3464
East Asian (EAS)
AF:
0.00
AC:
0
AN:
5188
South Asian (SAS)
AF:
0.00
AC:
0
AN:
4824
European-Finnish (FIN)
AF:
0.0000941
AC:
1
AN:
10630
Middle Eastern (MID)
AF:
0.00
AC:
0
AN:
294
European-Non Finnish (NFE)
AF:
0.00159
AC:
108
AN:
68036
Other (OTH)
AF:
0.000473
AC:
1
AN:
2116
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.495
Heterozygous variant carriers
0
7
13
20
26
33
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Genome Het
Variant carriers
0
4
8
12
16
20
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
Alfa
AF:
0.00127
Hom.:
0
Bravo
AF:
0.00110
TwinsUK
AF:
0.00135
AC:
5
ALSPAC
AF:
0.00156
AC:
6
ESP6500AA
AF:
0.000541
AC:
2
ESP6500EA
AF:
0.00158
AC:
13
ExAC
AF:
0.000886
AC:
107
EpiCase
AF:
0.00207
EpiControl
AF:
0.00136

ClinVar

Significance: Likely benign
Submissions summary: Benign:3
Revision: criteria provided, multiple submitters, no conflicts
LINK: link

Submissions by phenotype

not provided Benign:2
-
Breakthrough Genomics, Breakthrough Genomics
Significance:Likely benign
Review Status:criteria provided, single submitter
Collection Method:not provided

- -

Sep 01, 2024
CeGaT Center for Human Genetics Tuebingen
Significance:Likely benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

JMJD1C: BP4, BS2 -

Early myoclonic encephalopathy Benign:1
Feb 02, 2025
Labcorp Genetics (formerly Invitae), Labcorp
Significance:Likely benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

Computational scores

Source: dbNSFP v4.3

Name
Calibrated prediction
Score
Prediction
AlphaMissense
Benign
0.27
BayesDel_addAF
Benign
-0.47
T
BayesDel_noAF
Benign
-0.47
CADD
Benign
19
DANN
Uncertain
0.98
DEOGEN2
Benign
0.019
.;T;.
Eigen
Benign
-0.27
Eigen_PC
Benign
-0.10
FATHMM_MKL
Benign
0.60
D
LIST_S2
Uncertain
0.87
D;D;D
M_CAP
Benign
0.011
T
MetaRNN
Benign
0.011
T;T;T
MetaSVM
Benign
-1.0
T
MutationAssessor
Benign
0.76
.;N;.
PhyloP100
0.54
PrimateAI
Benign
0.29
T
PROVEAN
Benign
-1.1
.;N;N
REVEL
Benign
0.029
Sift
Benign
0.13
.;T;T
Sift4G
Benign
0.30
.;T;T
Polyphen
0.014
.;B;.
Vest4
0.31, 0.26
MVP
0.38
MPC
0.094
ClinPred
0.0045
T
GERP RS
4.9
RBP_binding_hub_radar
0.0
RBP_regulation_power_radar
1.7
Varity_R
0.067
gMVP
0.25
Mutation Taster
=93/7
polymorphism

Splicing

Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
0.0
Details are displayed if max score is > 0.2

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

Other links and lift over

dbSNP: rs201464655; hg19: chr10-64974224; API